CRUZ CARDENAS: Open Payments
NPI 1659004109 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,255 in 72 payments from 13 companies in 2025. Trend: 2023 $102 · 2024 $1,942 · 2025 $1,255
Food & beverage: $1,255
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $271 |
| Otsuka America Pharmaceutical, Inc. | 20 | $261 |
| Corium, LLC | 15 | $250 |
| Alkermes, Inc. | 4 | $80 |
| Lundbeck LLC | 3 | $71 |
| Teva Pharmaceuticals USA, Inc. | 4 | $65 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Axsome Therapeutics, Inc. | 2 | $38 |
Products named: VRAYLAR, Azstarys, REXULTI, ABILIFY ASIMTUFII, ARISTADA, COBENFY, TRINTELLIX, CAPLYTA.
Industry payments across TX — which companies pay providers there.
